IndiaTickerJubilant Pharmova Ltd - 530019 - Newspaper Advertisements Titled ''Notice Of 48Th Annual General Meeting, E-Voting, Record Date And Final Dividend InformationBSE · corporate action · pdf
Source filing Company dossier
Jubilant Pharmova
NSE:JUBLPHARMA · ISIN INE700A01033
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Jubilant Pharmova
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Business Responsibility and Sustainability Report FY 2025-2026 - Jubilant Pharmova LimitedNSE · business responsibility report · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Intimation To Shareholders About Deduction Of Tax At Source (TDS) On Final Dividend For FY 2025-26, If Approved By The Members At The Ensuing AGMBSE · corporate action · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Intimation Regarding Letter Dispatched To The Shareholders Whose Email Ids Are Not Registered, For AGM Notice, TDS Communication And Annual Report Of The Company For FY 2025-26BSE · annual report · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Please Find Attached Herewith The Notice Of 48Th Annual General Meeting Alongwith The Annual Report For The Financial Year 2025-26. The 48Th AGM Of The Company Will Be Held On Wednesday, August 26, 2026 Through Video Conferencing / Other Audio Visual Means.BSE · annual report · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Submission Of Copies Of Newspaper Advertisement Relating To Notice To Shareholders - Transfer Of Equity Shares/Dividend To IEPFBSE · corporate action · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled For August 07, 2026BSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Announcement Under Regulation 30 (LODR) - Communication Sent To Shareholders Relating To Notice Of Transfer To IEPFBSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Submission Of Copies Of Newspaper Publications - Annual General Meeting Of Jubilant Pharmova Limited Scheduled To Be Held On Wednesday, August 26, 2026 Through Video Conferencing/Other Audio Visual Means.
BSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Archived filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Archived filing Jubilant Pharmova Ltd - 530019 - Rectification Order From The Income Tax DepartmentBSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Approval For Grant Of Stock Options/Rsus/PsusBSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Disclosure under Regulation 30A of LODRBSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Receipt Of Rectification OrderBSE · exchange filing · pdf
Source filing Trading Window - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Tentative Approval For Panto-Prazole Sodium DRBSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Rectification Order Received From Tax Department In The Matter Of Jubilant Generics LtdBSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Completion Of USFDA InspectionBSE · exchange filing · pdf
Source filing Jubilant Pharmova Ltd - 530019 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Jubilant Pharmova Ltd - 530019 - USFDA Inspection Update - Contract Manufacturing Facility At Montreal, CanadaBSE · exchange filing · pdf
Source filing General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing